NO864556L - Fremgangsmaate ved fremstilling av insulinpreparat. - Google Patents

Fremgangsmaate ved fremstilling av insulinpreparat.

Info

Publication number
NO864556L
NO864556L NO86864556A NO864556A NO864556L NO 864556 L NO864556 L NO 864556L NO 86864556 A NO86864556 A NO 86864556A NO 864556 A NO864556 A NO 864556A NO 864556 L NO864556 L NO 864556L
Authority
NO
Norway
Prior art keywords
pct
procedure
insulin preparations
sec
manufacturing
Prior art date
Application number
NO86864556A
Other languages
English (en)
Other versions
NO174278B (no
NO174278C (no
NO864556D0 (no
Inventor
Per Balschmidt
Finn Benned Hansen
Original Assignee
Nordisk Gentofte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Gentofte filed Critical Nordisk Gentofte
Publication of NO864556L publication Critical patent/NO864556L/no
Publication of NO864556D0 publication Critical patent/NO864556D0/no
Publication of NO174278B publication Critical patent/NO174278B/no
Publication of NO174278C publication Critical patent/NO174278C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO864556A 1985-03-15 1986-11-14 Fremgangsmåte ved fremstilling av insulinderivat NO174278C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK119785A DK119785D0 (da) 1985-03-15 1985-03-15 Insulinpraeparat
PCT/DK1986/000023 WO1986005497A1 (en) 1985-03-15 1986-03-14 Novel insulin derivatives and pharmaceutical preparations containing these derivatives

Publications (4)

Publication Number Publication Date
NO864556L true NO864556L (no) 1986-11-14
NO864556D0 NO864556D0 (no) 1986-11-14
NO174278B NO174278B (no) 1994-01-03
NO174278C NO174278C (no) 1994-04-13

Family

ID=8102063

Family Applications (2)

Application Number Title Priority Date Filing Date
NO864556A NO174278C (no) 1985-03-15 1986-11-14 Fremgangsmåte ved fremstilling av insulinderivat
NO864555A NO864555L (no) 1985-03-15 1986-11-14 Fremgangsmaate ved fremstilling av insulinpreparat.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO864555A NO864555L (no) 1985-03-15 1986-11-14 Fremgangsmaate ved fremstilling av insulinpreparat.

Country Status (11)

Country Link
US (1) US5028586A (no)
EP (2) EP0216832B1 (no)
JP (2) JPS62502196A (no)
AT (2) ATE56022T1 (no)
AU (2) AU596968B2 (no)
DE (2) DE3673737D1 (no)
DK (3) DK119785D0 (no)
FI (2) FI864559A0 (no)
IL (2) IL78161A0 (no)
NO (2) NO174278C (no)
WO (2) WO1986005496A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK113585D0 (da) * 1985-03-12 1985-03-12 Novo Industri As Nye peptider
DK347086D0 (da) * 1986-07-21 1986-07-21 Novo Industri As Novel peptides
US5157021A (en) * 1985-03-15 1992-10-20 Novo Nordisk A/S Insulin derivatives and pharmaceutical preparations containing these derivatives
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
IE62879B1 (en) * 1987-02-25 1995-03-08 Novo Nordisk As Novel insulin derivatives
BR8803346A (pt) * 1988-06-30 1990-02-13 Biobras Bioquimica Do Brasil S Processo aperfeicoado para producao em larga escala de cristais de insulina purificada
BR8803345A (pt) * 1988-06-30 1990-02-13 Biobras Bioquimica Do Brasil S Processo aperfeicoado para producao em larga escala de cristais de insulina humana purificada
EP0425482B1 (en) * 1988-07-20 1993-08-18 Novo Nordisk A/S Human insulin analogs and preparations containing them
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
AU9172991A (en) 1990-12-07 1992-07-08 Cnc Development, Inc. Catalytic chemical reactor
DK33591D0 (no) * 1991-02-27 1991-02-27 Novo Nordisk As
ATE157010T1 (de) * 1991-05-24 1997-09-15 Amylin Pharmaceuticals Inc Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
AUPO269996A0 (en) * 1996-10-01 1996-10-24 Walter And Eliza Hall Institute Of Medical Research, The A method of prophylaxis and treatment
US5898067A (en) * 1997-02-07 1999-04-27 Novo Nordisk A/S Crystallization of proteins
JP2006504482A (ja) * 2002-11-01 2006-02-09 アンタレス・ファーマ・インコーポレーテッド 噴射式注射によるインスリン投薬
EP2368579A1 (en) 2004-01-21 2011-09-28 Novo Nordisk Health Care AG Transglutaminase mediated conjugation of peptides
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
JP2009527526A (ja) * 2006-02-21 2009-07-30 ノボ・ノルデイスク・エー／エス 単鎖インスリンのアナログとその製薬的製剤
WO2009099763A1 (en) * 2008-01-30 2009-08-13 Indiana University Research And Technology Corporation Ester-based peptide prodrugs
CN102300580A (zh) * 2008-12-19 2011-12-28 印第安纳大学研究及科技有限公司 二肽连接的药剂
AR074811A1 (es) 2008-12-19 2011-02-16 Univ Indiana Res & Tech Corp Profarmaco de peptido de la superfamilia de glucagon basados en amida
CN103119057B (zh) 2010-06-24 2016-06-15 印第安纳大学研究及科技有限公司 基于酰胺的胰岛素前药
JP6392123B2 (ja) 2011-12-20 2018-09-19 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ 糖尿病治療のためのｃｔｐ系インスリンアナローグ
EP3395358B1 (en) 2012-09-26 2019-11-06 Indiana University Research and Technology Corporation Insulin analog dimers
US20160024169A1 (en) 2013-03-14 2016-01-28 Indiana University Research And Technology Corporation Insulin-incretin conjugates
JP6701208B2 (ja) 2014-09-24 2020-05-27 インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション 脂質化アミド系インスリンプロドラッグ
WO2016049190A1 (en) 2014-09-24 2016-03-31 Indiana University Research And Technology Corporation Incretin-insulin conjugates

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903068A (en) * 1972-12-26 1975-09-02 Us Health Education & Welfare Facile synthesis of human insulin by modification of porcine insulin
JPS55138393A (en) * 1979-04-13 1980-10-29 Shionogi & Co Ltd Semisynthesis of insulin
JPS55138391A (en) * 1979-04-13 1980-10-29 Shionogi & Co Ltd New synthetic method of peptide derivative
NO153061C (no) * 1979-04-13 1986-01-08 Shionogi & Co Fremgangsmaate for fremstilling av et b30-threonininsulin
DK147437A (en) * 1980-02-11 1900-01-01 Process for preparing human insulin or threonine B30 esters of human insulin, or a salt or complex thereof
US4421685A (en) * 1980-03-27 1983-12-20 Eli Lilly And Company Process for producing an insulin
DK319780A (da) * 1980-07-24 1982-01-25 Forenede Bryggerier As Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
DE3327709A1 (de) * 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
DK113585D0 (da) * 1985-03-12 1985-03-12 Novo Industri As Nye peptider

Also Published As

Publication number Publication date
FI864560A0 (fi) 1986-11-10
FI864560A (fi) 1986-11-10
NO864555D0 (no) 1986-11-14
DE3687500D1 (de) 1993-02-25
IL78160A0 (en) 1986-07-31
DK545786D0 (da) 1986-11-14
EP0216832B1 (en) 1990-08-29
FI93460B (fi) 1994-12-30
DK545686A (da) 1986-11-14
AU596968B2 (en) 1990-05-24
DK545686D0 (da) 1986-11-14
FI864559A (fi) 1986-11-10
EP0216833B1 (en) 1993-01-13
DE3687500T2 (de) 1993-07-01
AU5622786A (en) 1986-10-13
DK119785D0 (da) 1985-03-15
IL78160A (en) 1991-06-10
NO174278B (no) 1994-01-03
AU5622686A (en) 1986-10-13
FI864559A0 (fi) 1986-11-10
EP0216832A1 (en) 1987-04-08
ATE84546T1 (de) 1993-01-15
EP0216833A1 (en) 1987-04-08
IL78161A0 (en) 1986-07-31
DK159856B (da) 1990-12-17
US5028586A (en) 1991-07-02
WO1986005497A1 (en) 1986-09-25
WO1986005496A1 (en) 1986-09-25
FI93460C (fi) 1995-04-10
DK545786A (da) 1986-11-14
DE3673737D1 (de) 1990-10-04
DK159856C (da) 1991-05-06
JPS62502538A (ja) 1987-10-01
NO174278C (no) 1994-04-13
JPS62502196A (ja) 1987-08-27
ATE56022T1 (de) 1990-09-15
NO864556D0 (no) 1986-11-14
NO864555L (no) 1986-11-14

Similar Documents

Publication Publication Date Title
NO864556L (no) Fremgangsmaate ved fremstilling av insulinpreparat.
CY2024A (en) 3-Demethyl-4-fluoro-mevalonic-acid derivatives process for their preparation pharmaceutical preparations based on those compounds their use and intermediates
NO931919L (no) Optisk aktivt 5h-pyrrolo(3,4-b)pyrazinderivat, dets fremstilling samt farmasoeytiske preparater inneholdende derivatet
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AR243180A1 (es) Procedimiento para la obtencion de 3,4-dihidro-2h-benzopiranos sustituidos.
DK642588A (da) Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
IL92268A0 (en) 14alpha,17alpha,ethanoestratriene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE3662520D1 (en) Cis-1,3,5-triamino 2,4,6-cyclohexanetriol derivatives, their use, process for their preparation and pharmaceutical preparations containing them
DK0588177T3 (da) Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet
DK578589A (da) Farmaceutisk praeparat indeholdende labdanterpenoidderivater og pyrimido(6,1-a)isoquinolin-4-onderivater, dets fremstilling og anvendelse
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ZA874536B (en) Pyrido(1,8)naphthyridinones,processes for the preparation thereof,and the use thereof,and preparations containing these compounds
EP0234348A3 (en) N-glycosyl amide derivatives, method for their preparation and their use as medicaments
IL90187A0 (en) Method for treating an auto-immune disease using succinyl-acetone and pharmaceutical compositions containing the same
DK131188A (da) 3-(2-halogenalkyl)-1,4-oxathiiner og 2(2-halogenalkyl)-1,4-dithiiner, samt farmaceutiske praeparater indeholdende disse til behandling af leukaemi og tumorer
ATE57935T1 (de) 16,17-acetalsubstituierte pregnan-21-saeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
IL90191A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ATE53214T1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
ATA273988A (de) Neue verwendung von 11,28-dioxa-4-azatricyclo- (22.3.1.04,9)octacos-18-en-derivaten und sie enthaltende pharmazeutische zubereitungen
IL85508A (en) 2-substituted-4-(2-benzyl-aminophenyl)-1,4,5,7-tetra-hydro-5-oxofuro(3,4,-b)-pyridine-3-carboxylic acid derivatives and pharmaceutical compositions containing them